Conférences  >  Médecine & Soins de Santé  >  Pharmacologie et développement des médicaments

IIT (BHU), Varanasi

Drug Discovery and Translational Healthcare 2025 (DDTH 2025) will be held on December 2-3, 2025, at the School of Biochemical Engineering, Indian Institute of Technology (BHU) Varanasi, India, in collaboration with two prestigious societies, Bioinformatics and Drug Discovery Society (BDDS)" and "Biotechnology Society of India (BSI) ". This two-day event will feature keynote, plenary, and invited lectures by leading scientists and academics, alongside oral and poster presentations by students. The conference will focus on applied bioinformatics and various aspects of translational healthcare. DDTH 2025 aims to offer an exceptional platform for staying up-to-date with the latest research, fostering information exchange, and enabling networking opportunities among researchers. We warmly invite you to submit your posters and register for the conference.

Organizing Chairman/Secretaries;     Tél.: [0000000000];     Email.: ddthiitbhuvaranasi@gmail.com

Computer Aided Drug Design/Structure-Based Drug Designing, Biotechnology and Healthcare, Omics and Bioinformatics for healthcare, Protein targets and therapeutic proteins

ComplianceOnline

This 2-day seminar explores the unique challenges facing quality functions of pharmaceutical and biotechnology companies. Attendees will learn practical implementation solutions as well as best practice descriptions that will allow management to effectively assess, manage and mitigate risk of poorly designed studies. Participants will learn statistical methods related to ICH guidelines and will discover how regulatory agencies, such as the FDA expect organizations to meet these guidelines.

ICH Quality Guidelines seminar, Statistical Considerations seminar, ICH guidelines, pharmaceutical manufacture, biotech manufacture, statistical methods, ICH guidelines compliance, statistical methods tools, statistical methods templates, regression analysis, confidence intervals, tolerance intervals, appropriate sample size, risk probability, process characterization for design space, FDA regulatory requirements

Biotechnologie,    Pharmacogénétique, Médecine personnalisée

The 1st Al Ain Region Pharmacy Conference, taking place on 6–7 December 2025 at Al Ain Rotana Hotel, serves as a regional platform to foster professional exchange and highlight key developments in pharmaceutical and clinical research. The conference focuses on enhancing pharmacy practice through evidence-based learning and skill development, welcoming pharmacists, clinical specialists, technicians, academicians, researchers, students, and other healthcare professionals. It is led by expert chairs from SEHA, ensuring strong clinical leadership and direction.

CHI

Join a vibrant community of scientists, trailblazers, and industry leaders at PepTalk 2026, as we mark 25 years of accelerating breakthroughs in biotherapeutic discovery and development. Renowned as one of the most influential events in protein science, PepTalk is where fresh ideas ignite, collaborations flourish, and next-generation solutions take shape.

This year’s expanded agenda features symposia and conference tracks, covering protein expression, production platforms, lab automation for higher throughput, analytical characterization and preformulation strategies for novel modalities, antibody discovery and development, and new this year - expression and development of therapeutic peptides and miniproteins.

Tél.: [781.972.5400];     Email.: chi@healthtech.com

FDAMap

Are you ready to elevate your clinical trial process with the power of smart trials? This one-day virtual program is your gateway to transforming how trials are conducted. Imagine cutting timelines, slashing costs, and driving incredible ROI with advanced virtual tools, data-driven methodologies, and streamlined operations! This program will take you from traditional trial challenges to a smart, virtual-first strategy that amplifies results and redefines success.

FDA, Smart Clinical Trials, Clinical Trials, FDA Regulation, FDA Compliance

Législation en médecine et pharmacologie,    Médecine translationnelle, essais cliniques

FDAMap

Clinical trials are highly regulated multi-dimensional projects that require constant interactions between the regulators and the sponsors, investigators, other personnel, and even patients involved in the conduct of a given trial. There are many diverse tasks involved in the conduct of a clinical trial starting from the development of a clinical trial protocol, finding and starting clinical trial sites, filing of an IND or IDE application, approvals from IRBs, numerous documents need to be collected to demonstrate compliance with regulations; managing supplies, collecting data, writing reports, and many other things. Clinical project managers need to understand, implement, and trouble-shoot practically all aspects of the clinical trial under them. Clinical project managers have to build teams and have clear perspective of what may be needed for assuring compliance with FDA requirements of a given clinical trial at all times. This one-of-a-kind program will train you in regulatory affairs, clinical operations, monitoring, patient recruitment and retention, planning, medical writing, safety monitoring and practically all major aspects of running a clinical trial.

FDA, Clinical Project Management, FDA Regulation, FDA Compliance

Législation en médecine et pharmacologie,    Médecine translationnelle, essais cliniques

FDAMap

Each year FDA receives about 3000 applications for new devices via the 510k process, and about 60% of them are rejected either for poor quality application that cannot even be reviewed or for other technical reasons. Submissions to the FDA that are poorly organized, do not follow current practices, contain inconsistencies between documents, have missing or incomplete content, or poor structure will result in significant delays in the clearance process. With multiple review cycles, up to 90 days each, rejections by FDA could stretch the 510k clearance time-lines to 8 months or more. Most of the refuse-to-accept deficiencies are due to the inexperience of the 510k writers, who ignore the FDA rules. Writing and assembling a complete and well structured 510(k) submission will certainly improve the likelihood of FDA clearance on the first round.

FDA, 510(k) Submissions, FDA Regulation, FDA Compliance

Uventia Global

The 6th Extractables & Leachables Summit 2026 is a premier two day event bringing together global experts from pharma, biotech, medical devices and regulatory agencies to discuss the latest trends, challenges and innovations in E&L science.

Email.: info@uventia.com

Global Regulatory Frameworks & Harmonization, Packaging and Route Specific Risks, Biologics and Secondary Leachables, E&L in Medical Devices & Their Risk Assessment, Single Use Systems & Process Equipment, Sustainability in E&L Testing, Digitalization & AI Modeling in E&L, Lifecycle Integration of E&L Strategies

Législation en médecine et pharmacologie,    Spectroscopie de masse, chromatographie et résonance magnétique nucléaire

FDAMap

SOP deficiencies are one of the top 5 findings in FDA audits. The entire Quality Management System (QMS) of an organization could be severely compromised due to SOP defects. Formal written Standard Operating Procedures (SOPs) are required both by the FDA and EMA. Almost every deficiency identified in FDA’s 483s and Warning Letters can be traced back to deficiencies in SOPs at an organization. SOPs are often inadequate, miss important elements, do not contain important tools to increase compliance with the SOPs and, many times, are hard for the personnel who follow them to understand. They are frequently poorly written, communicated, monitored and enforced. This workshop will provide step by step instructions to create SOPs for FDA-regulated organizations.

FDA, SOPs, FDA Regulation, FDA Compliance

Législation en médecine et pharmacologie,    Médecine translationnelle, essais cliniques

Virtue Insight

This event will bring together top pharmaceutical, biotechnology and regulatory representatives under one roof that will address the key issues of the industry. Take a chance and make it count by attending our event to network with your peers, exchange expertise and experiences, and arm yourself with the latest information to take your department to the next level. It gives me great pleasure in welcoming all of you to the Virtue Insight’s 40th Pharmacovigilance UK & EU 2026. I wish and pray that all our efforts will be beneficial to our industries and to our all at large.

Tél.: [+44 2035093779];     Email.: Kavitha@virtueinsight.co.in

Pharmacovigilance, regulatory affairs, Drug Safety, Drug Development, patient safety, RiskManagement, Pharmaceuticals, healthcare

FDAMap

In the field of regulatory affairs, professionals often encounter the task of writing complex documents for diverse audiences. These documents encompass a wide range, including reports, protocols, clinical trial and marketing approval applications, technical reports on studies, and various communication documents. The purpose of this exclusive technical writing workshop is to provide regulatory professionals with valuable insights into best practices and regulatory strategies for crafting effective documents. The workshop will cover a spectrum of writing needs, from simple issues like minutes of meetings and correspondence notes to more intricate tasks such as producing comprehensive nonclinical and clinical study reports, as well as regulatory submissions to regulatory bodies such as FDA, EMA, Health Canada, and others.

FDA, ​Technical Writing, Regulatory Writing, FDA Regulation, FDA Compliance

Législation en médecine et pharmacologie,    Médecine translationnelle, essais cliniques

Banff International Research Station for Mathematical Innovation and Discovery (BIRS)

The vaccine development pipeline is a time, cost and labour-intensive process. Mathematical and computational methods can alleviate challenges related to this intensive process as well as providing further insights into the efficacy and safety of vaccines. These methods are key components of model-informed vaccine development (MIVD) and quantitative systems pharmacology/toxicology (QSP/T). MIVD and QSP/T can be used in tandem to better understand the biological processes and outcomes from vaccination administration, spurring future research. This workshop will strengthen and contribute to the ongoing development of this interdisciplinary community of biologists, mathematicians and vaccinologists.

Mathématiques appliquées (en général),    Simulation

American Society for Experimental Neurotherapeutics (ASENT)

ASENT's 2026 Annual Meeting is the premier neuroscience and neurotherapeutics conference where leaders from providers and prescribers, employers, investors, fast-growing startups, big pharma, policymakers, funders & innovation centers gather to improve the process of bringing neurotherapeutics to market.

Tél.: [8332731556];     Email.: jessica@asent.org

Neurology, Neurotherapeutics, Neuroscience, Biotech, Bioengineering, FDA, NIH, Drug Development, Pipeline Presentations

ELETS Technomedia

The expo will be taking place at Hitex Exhibition Centre from 23rd- 25th April (Thu-Sat) 2026, With the concurrent events Next Gen Pharma Summit and Healthcare Innovation Expo & Summit 2026.It will unite pharmaceutical companies, Drug manufacture, healthcare providers, policymakers, researchers, and technology leaders from around the world on one powerful platform to share knowledge, explore solutions, and foster strategic partnerships.

Tél.: [09560050693];     Email.: indiapharmaexpo1@gmail.com

Pharamaceuticals, Healthcare Technologies, Vaccines, Nanotechnology, Smart Molecule

Salons, foire-exposition,    Génie biomédical

The expo will be taking place t Hitex Exhibition Centre from 23rd- 25th April (Thu-Sat). 2026, with the concurrent events NextGenPharma Summit and Healthcare Innovation Expo & Summit 2026.It will unite pharmaceutical companies,Drug manufacture, healthcare providers, policymakers, researchers, and technology leaders from around the world on one powerful platform to share knowledge, explore solutions, and foster strategic partnerships.

Project Head;     Tél.: [95600 50693];     Email.: milan.jena@elets.in

healthcare, science, pharmaceuticals, biotenchnology, nenotechnology, health

Banff International Research Station for Mathematical Innovation and Discovery (BIRS)

The landscape of drug design is rapidly evolving, with computational methods and artificial intelligence (AI) playing an increasingly important role. This workshop aims to explore cutting-edge mathematical approaches that are transforming the field of computational drug design. We will delve into multiscale modeling techniques that bridge the gap between molecular and macroscopic levels, providing a comprehensive understanding of drug interactions and dynamics. Additionally, we will highlight the integration of generative AI and machine learning (ML) algorithms in predicting drug efficacy, optimizing molecular structure, speeding up drug repurposing, understanding potential toxicity, and thus accelerating the drug discovery and development process. By bringing together diverse experts from academia, industry, and innovation support organizations, and adding early career researchers to the mix, this workshop will foster interdisciplinary collaboration and innovation. Participants will gain insights into the latest developments, discuss challenges, and explore future opportunities in the quest for more effective and efficient drug design.

Mathématiques appliquées (en général),    Réseaux de neurones et intelligence artificielle, apprentissage automatique

UK Biotech Day is an international premier event for life science leaders, innovators, investors and service providers. Our mission is to unite the UK’s vibrant biotech ecosystem, spanning world-class research, dynamic startups, big pharma, and visionary investors, to drive breakthrough partnerships. Join us to discover new opportunities, forge strategic alliances, and help shape the next era of biotech success in the UK and the world.

Head of Partnerships & Business Development;     Tél.: [+443301338933‬];     Email.: jane.smith@ukbiotechday.org

pharmaceutical industry events, pharma, biotech, biotech conferences, Pharma conferences, pharma biotech conferences, pharma biotech dealmaking conferences, pharma business development and licensing conference, pharma congress, pharmaceuticals, Biotech events, Pharma Events, Pharma Partnering, Partnering Conference, Business Development Conference, Licensing Conference, BD&L Conference, Pharma Deals, Biotech Deals, Pharma-Biotech Deals, R&D Collaborations, Conference, Networking, Event, Europe, Life Sciences, pharmaceuticals, pharma, biotech

Biotechnologie,    Législation en médecine et pharmacologie

Creovate Conferences

At Creovate Conferences, we believe scientific gatherings should be more than lectures—they should ignite collaboration, drive innovation, and influence global health and regulatory policy. That’s the core vision behind the International Conference on Toxicology and Applied Pharmacology (Toxicology2026), taking place from May 28–30, 2026, in the vibrant city of Barcelona, Spain.

International Conference on Toxicology and Applied Pharmacology;     Email.: toxicology@creovateconferences.com

Toxicology Applied Pharmacology Drug Toxicity Clinical Toxicology Experimental Pharmacology Pharmacokinetics and Pharmacodynamics Molecular Toxicology Environmental Toxicology Occupational Toxicology Forensic Toxicology Analytical Toxicology Pharmacological Research Neurotoxicology Immunotoxicology Genetic Toxicology Reproductive and Developmental Toxicology

Innovinc International

Tél.: [+14084650048];     Email.: brian.mitchell@pharmanext.org

Pharma Conferences Czech Republic, Medical & Pharma Events in Prague - Czech Republic, Digital Healthcare Conference, Annual Global Pharmacovigilance Summit, Pharmaceutical Conferences, Pharmaceutical events, Drug Delivery Conferences, Clinical Pharmacy, Medical and pharma events Prague, International Conference on Pharmacy and Pharmacology, Pharma Care, Pharma Research Events, Global Biopharmaceutical Events, Pharma Research Conferences in Europe 2026, PharmaWorld Congress, Innovative Pharma Horizons, PharmaBridge Global Meet, Global Pharma Connect, Pharma Frontiers Summit, NextGen Pharma Conference 2026, Evidence to Excellence Conference, Pharma Safety Event 2026, Pharma Trials, Molecule to Medicine Summit, Pharmacology of Infectious Diseases Conferences 2026, Pharmacology Conferences, Clinical Pharmacology, Drug synthesis and Formulation event, International Summit on Toxicology and applied Pharmacology, International Congress of Toxicology 2026, Pharmaceutical sciences Conferences, Nanotechnology Conferences, International Conference on Nanotechnology, PBPK Modelling and Simulation, Novel Targets in Pharmacology & Drug Discovery, World Congress on Pharmacology & Therapeutics, Global Summit on Clinical & Experimental Pharmacology, International Conference on Drug Development & Pharmacodynamics, Cancer Pharmacology & Chemotherapy Advances, Pharmacokinetics & Pharmacodynamics Workshop, Pediatric & Geriatric Pharmacology Summit, oxicology & Environmental Pharmacology Meet, Immunopharmacology & Biologics Symposium, Neuropharmacology & Psychopharmacology Summit, Cardiovascular & Metabolic Pharmacology Congress, Novel Targets in Pharmacology & Drug Discovery, International Conference on Drug–Drug Interactions & Therapeutics, Global Summit on Pharmacokinetics and Drug Interactions, Clinical Pharmacology Forum, Advances in Drug Interaction Science & Safety, Symposium on Predictive Models in Drug–Drug Interactions.

Kenes Exhibitions

Join us for the 3rd RNA Horizons Conference, taking place September 16–18, 2026, in Munich, Germany. This premier event brings together scientists, clinicians, and biotech innovators to explore the latest advancements in RNA therapeutics, spanning established modalities as well as emerging areas such as ASOs and RNA structure–based therapies. Discussions will cover key trends, including pipeline diversification, enhanced RNA modalities, AI integration, and improved delivery technologies. Notably, the conference will focus on translating discoveries into viable therapies, with insights into commercialization and market access.

Tél.: [972 747457435];     Email.: skrein@kenes-exhibitions.com

RNA therapeutics, RNA biology, RNA medicine, RNA delivery, antisense oligonucleotides, self-amplifying RNA, RNA-based therapy, cancer research, oncology innovation, RNA stability, clinical translation, biotechnology, life sciences, European biotech, Horizon Europe, CANCERNA consortium, Hadassah Cancer Research Institute, RNA Horizons, RNA conference Europe, Munich 2026, RNA innovation, European research collaboration

Biotechnologie,    Médecine translationnelle, essais cliniques